Research Article
Preoperative and Postoperative Bone Mineral Density Change and Risk Factor Analysis in Patients with a GH-Secreting Pituitary Adenoma
Table 4
Correlation analysis of clinical data and the BMD Z score.
| | L1 | L2 | L3 | L4 | L1–L4 | L2–L4 | Femoral neck | Ward triangle | Trochanter | Total hip |
| Age (years) | r | −0.110 | −0.125 | −0.156 | −0.125 | −0.123 | −0.131 | −0.017 | 0.068 | 0.056 | −0.039 | | 0.506 | 0.449 | 0.343 | 0.447 | 0.456 | 0.425 | 0.919 | 0.682 | 0.735 | 0.816 | BMI (kg/m2) | r | −0.049 | −0.048 | 0.069 | −0.034 | −0.014 | −0.023 | 0.082 | −0.102 | 0.054 | 0.235 | | 0.768 | 0.772 | 0.675 | 0.835 | 0.931 | 0.887 | 0.618 | 0.535 | 0.742 | 0.150 | Disease duration (months) | R | −0.389 | −0.370 | −0.371 | −0.371 | −0.413 | −0.393 | −0.280 | −0.276 | −0.319 | −0.324 | | 0.014 | 0.021 | 0.020 | 0.020 | 0.009 | 0.013 | 0.084 | 0.088 | 0.048 | 0.044 | Adenoma size (mm) | r | 0.070 | 0.183 | 0.144 | 0.147 | 0.139 | 0.155 | 0.102 | 0.120 | 0.104 | 0.114 | | 0.670 | 0.264 | 0.383 | 0.371 | 0.400 | 0.346 | 0.535 | 0.466 | 0.528 | 0.488 | GH (ng/mL) | r | 0.240 | 0.272 | 0.186 | 0.178 | 0.229 | 0.214 | 0.194 | 0.101 | 0.191 | 0.192 | | 0.140 | 0.094 | 0.257 | 0.277 | 0.161 | 0.190 | 0.236 | 0.541 | 0.245 | 0.241 | IGF-1 (ng/mL) | r | 0.021 | 0.097 | 0.097 | 0.096 | 0.086 | 0.106 | 0.191 | 0.041 | 0.133 | 0.193 | | 0.897 | 0.556 | 0.559 | 0.563 | 0.603 | 0.522 | 0.244 | 0.802 | 0.421 | 0.240 | IGF-1 burden (ng/mL month) | r | −0.326 | −0.273 | −0.277 | −0.267 | −0.319 | −0.298 | −0.150 | −0.197 | −0.213 | −0.174 | | 0.042 | 0.093 | 0.088 | 0.100 | 0.048 | 0.066 | 0.362 | 0.230 | 0.194 | 0.291 | FT3 (pg/mL) | r | −0.006 | −0.077 | −0.066 | −0.057 | −0.072 | −0.073 | −0.215 | −0.231 | −0.128 | −0.117 | | 0.970 | 0.643 | 0.692 | 0.729 | 0.665 | 0.659 | 0.188 | 0.157 | 0.436 | 0.477 | FT4 (pg/mL) | r | −0.195 | −0.176 | −0.081 | −0.096 | −0.124 | −0.118 | −0.100 | −0.057 | −0.095 | −0.107 | | 0.234 | 0.283 | 0.623 | 0.559 | 0.452 | 0.474 | 0.543 | 0.728 | 0.564 | 0.518 | PRL (ng/mL) | r | −0.129 | −0.184 | −0.219 | −0.240 | −0.227 | −0.234 | −0.329 | −0.255 | −0.361 | −0.313 | | 0.435 | 0.263 | 0.180 | 0.142 | 0.164 | 0.151 | 0.041 | 0.117 | 0.024 | 0.053 | Ca (mmol/L) | r | 0.140 | 0.057 | 0.038 | 0.001 | 0.083 | 0.054 | 0.230 | 0.250 | 0.233 | 0.136 | | 0.396 | 0.730 | 0.819 | 0.995 | 0.614 | 0.746 | 0.159 | 0.124 | 0.154 | 0.411 | P (mmol/L) | r | 0.077 | 0.048 | 0.040 | −0.039 | 0.024 | 0.015 | −0.015 | −0.022 | −0.025 | 0.042 | | 0.641 | 0.771 | 0.808 | 0.812 | 0.883 | 0.929 | 0.929 | 0.897 | 0.878 | 0.801 |
|
|
BMI: body mass index; GH: growth hormone; IGF-1: insulin-like growth factor-1; FT3: free triiodothyronine; FT4: free thyroxine; PRL: prolactin; Ca: calcium; P: phosphorus.
|